Key result
Over-anticoagulation occurred in 36-53% of warfarinised hospital patients across two audits, with haemorrhagic events occurring in 40% and 18% of patients.
Why the study?
How frequent is over-anticoagulation in warfarinised hospital patients and how is it managed?
Observational (n=58)
How frequent is over-anticoagulation in warfarinised hospital patients and how is it managed?
Over-anticoagulation is common in warfarinised hospital patients, often driven by drug interactions, highlighting the need for improved management practices.
Answers are grounded in this paper and cite their sources.
Frequent over-anticoagulation in warfarinised inpatients warrants vigilance; Level 3 data leaves open optimal mitigation strategies.
Aim To determine the number of warfarinised hospital patients experiencing over‐anticoagulation; to identify how over‐anticoagulation is managed and whether local guidelines are adhered to. Method 2 prospective one‐week clinical audits were conducted in 2005 (Audit 1) and 2008 (Audit 2). The medical notes, drug charts and anticoagulation charts of warfarinised patients admitted to hospital were reviewed. The following data were collected: medical histories, warfarin regimen, international normalised ratio results, clinical events and over‐anticoagulation clinical management and treatment options. Results Data were collected for 58 patients (Audit 1: n = 30; Audit 2: n = 28). At least one‐third of all patients experienced over‐anticoagulation (Audit 1: 53%; Audit 2: 36%). Haemorrhagic events occurred in 40% of patients in Audit 1 and 18% in Audit 2 (p = 0.06) – not all were associated with elevated international normalised ratios. Most cases of over‐anticoagulation were managed by withholding warfarin doses and one case (Audit 2) required Prothrombinex. Drug interactions were the most common risk factor (> 50% of patients) for over‐anticoagulation in both audits. Problems with documentation were more prevalent in Audit 1 than in Audit 2. Conclusion Over‐anticoagulation is a common occurrence in warfarinised hospital patients. Hospital over‐anticoagulation management practices need to be reviewed to ensure safe and efficacious anticoagulation.
No takes yet. Share an insight, caveat, or question.
Bajorek et al. (2009) conducted an observational in Warfarinised hospital patients (n=58). Warfarin therapy was evaluated on Haemorrhagic events (p=0.06). Over-anticoagulation occurred in 36-53% of warfarinised hospital patients across two audits, with haemorrhagic events occurring in 40% and 18% of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: